exenatide, an experimental new drug for type 2 diabetes

There's excitement about exenatide, an experimental new drug for type 2 diabetes.

It's made from the saliva of the Gila monster.

It's the first in a new class called incretin mimetics.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote